Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14
about
Macrolide therapy in respiratory viral infectionsMacrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.Targeting mucus hypersecretion: new therapeutic opportunities for COPD?Melatonin inhibits MUC5AC production via suppression of MAPK signaling in human airway epithelial cells.Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line.
P2860
Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14
description
im März 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2008
@uk
name
Erythromycin attenuates MUC5AC ...... cheal cells infected with RV14
@en
Erythromycin attenuates MUC5AC ...... cheal cells infected with RV14
@nl
type
label
Erythromycin attenuates MUC5AC ...... cheal cells infected with RV14
@en
Erythromycin attenuates MUC5AC ...... cheal cells infected with RV14
@nl
prefLabel
Erythromycin attenuates MUC5AC ...... cheal cells infected with RV14
@en
Erythromycin attenuates MUC5AC ...... cheal cells infected with RV14
@nl
P2093
P2860
P1433
P1476
Erythromycin attenuates MUC5AC ...... cheal cells infected with RV14
@en
P2093
Daisuke Inoue
Hidetada Sasaki
Hiroyasu Yasuda
Muneo Numasaki
Mutsuo Yamaya
Takahiko Sasaki
P2860
P304
P356
10.1111/J.1440-1843.2007.01227.X
P50
P577
2008-03-01T00:00:00Z